Harrow Health, Inc. (NASDAQ:HROW) is set to announce third quarter earning results on Monday 9th November 2020, after market close.
Analysts surveyed by Thomson Reuters are predicting, HROW to report 3Q20 income of $ 0.03 per share.
For the full year, analysts anticipate top line of $ 41.93 million, while looking forward to loss of $ 0.47 per share bottom line.
Previous Quarter Performance
Harrow Health, Inc. reported loss for the second quarter of $ 0.01 per share, from the revenue of $ 8.06 million. The consensus estimates are loss of $ 0.10 per share from $ 5.70 million in revenue. The bottom line results beat street analysts by $ 0.09 or 90.00 percent, at the same time, top line results outshined analysts by $ 2.36 million or 41.40 percent.
Stock Performance
On Friday, shares of Harrow Health, Inc. has traded high as $ 5.12 and has cracked $ 4.88 on the downward trend, reaching $ 4.93 with volume of 77.80 thousand shares.
According to the previous trading day, closing price of $ 4.93, representing a 47.15 % increase from the 52 week low of $ 3.33 and a 38.13 % decrease over the 52 week high of $ 7.92.
The company has a market capital of $ 126.45 million and is part of the Healthcare sector and Drug Manufacturers – Specialty & Generic industry.
Conference Call
Harrow Health, Inc. will be hosting a conference call at 4:45 PM eastern time on 9th November 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.harrowinc.com
Harrow Health, Inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the United States. The company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. It also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.
